|
1
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Said A and Wells J: Management of
hepatocellular carcinoma. Minerva Med. 100:51–68. 2009.PubMed/NCBI
|
|
3
|
Llovet JM, Real MI, Montaña X, Planas R,
Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al:
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: A
randomized controlled trial. Lancet. 359:1734–1739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
European Association For The Study Of The
Liver; European Organisation For Research And Treatment Of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guan YS, He Q and Wang MQ: Transcatheter
arterial chemoembolization: History for more than 30 Years. ISRN
Gastroenterol. 2012:4806502012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldberg SN and Ahmed M: Minimally
invasive image-guided therapies for hepatocellular carcinoma. J
Clin Gastroenterol. 35:(5 Suppl 2). S115–S129. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siriwardana RC, Niriella MA, Dassanayake
AS, Liyanage CA, Upasena A, Sirigampala C and de Silva HJ: Factors
affecting post-embolization fever and liver failure after
trans-arterial chemo-embolization in a cohort without background
infective hepatitis- a prospective analysis. BMC Gastroenterology.
15:962015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poggi G, Pozzi E, Riccardi A, Tonini S,
Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P,
Pagella C, et al: Complications of image-guided transcatheter
hepatic chemoembolization of primary and secondary tumours of the
liver. Anticancer Res. 30:5159–5164. 2010.PubMed/NCBI
|
|
10
|
Peng W, Li C, Zhu WJ, Wen TF, Yan LN, Li
B, Wang WT and Yang JY: Prognostic value of the platelet to
lymphocyte ratio change in liver cancer. J Surg Res. 194:464–470.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
People's Republic of China Ministry of
Health: Guideline for the diagnosis and treatment of primary liver
cancer (2011). J Clinical Hepatol. 27:1141–1159. 2011.(in
Chinese).
|
|
13
|
Ooka Y, Chiba T, Ogasawara S, Motoyama T,
Suzuki E, Tawada A, Kanai F and Yokosuka O: Partial splenic
embolization with transarterial chemoembolization in patients with
hepatocellular carcinoma accompanied by thrombocytopenia. Biomed
Res Int. 2014:9606282014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lencioni R, Petruzzi P and Crocetti L:
Chemoembolization of hepatocellular carcinoma. Semin Intervent
Radiol. 30:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peck-Radosavljevic M, Sieghart W,
Kölblinger C, Reiter M, Schindl M, Ulbrich G, Steininger R, Müller
C, Stauber R, Schöniger-Hekele M, et al: Austrian Joint
ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial
chemoembolization (TACE) in hepatocellular carcinoma. Wien Klin
Wochenschr. 124:104–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Facciorusso A, Licinio R, Muscatiello N,
Di Leo A and Barone M: Transarterial chemoembolization: Evidences
from the literature and applications in hepatocellular carcinoma
patients. World J Hepatol. 7:2009–2019. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Llovet JM, Bru C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mazioti A, Gatselis NK, Rountas C, Zachou
K, Filippiadis DK, Tepetes K, Koukoulis GK, Fezoulidis I and
Dalekos GN: Safety and efficacy of transcatheter arterial
chemoemboliazation in the real-life management of unresectable
hepatocellular carcinoma. Hepat Mon. 13:e70702013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qamar AA, Grace ND, Groszmann RJ,
Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R,
Escorsell A, et al: Incidence, prevalence, and clinical
significance of abnormal hematologic incidences in compensated
cirrhosis. Clin Gastroenterology Hepatol. 7:689–695. 2009.
View Article : Google Scholar
|
|
20
|
Giannini EG: Review article:
Thrombocytopenia in chronic liver disease and pharmacologic
treatment options. Aliment Pharmacol Ther. 23:1055–1065. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tohill PJ, Green S and Ferguson F:
Platelet dynamics in chronic liver disease with special reference
to the role of the spleen. Clin Pathol. 30:367–371. 1977.
View Article : Google Scholar
|
|
22
|
Rios R, Sangro B, Herrero I, Quiroga J and
Prieto J: The role of thrombopoietin in the thrombocytopenia of
patients with liver cirrhosis. Am J Gastroenterol. 100:1311–1316.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tahara H, Takagi H, Sato K, Shimada Y,
Tojima H, Hirokawa T, Ohyama T, Horiuchi K, Naganuma A, Arai H, et
al: A retrospective cohort study of partial splentic embolization
for antiviral therapy in chronic hepatitis C with thrombocytopenia.
J Gastroenterology. 46:1010–1019. 2011. View Article : Google Scholar
|
|
24
|
Ishikawa T, Kubota T, Horigome R, Kimura
N, Honda H, Iwanaga A, Seki K, Honma T and Yoshida T: Concurrent
partial splenic embolization with transcatheter arterial
chemoembolization for hepatocellular carcinoma can maintain hepatic
functional reserve. Hepatology Res. 44:1056–1061. 2014. View Article : Google Scholar
|
|
25
|
Poggi G, Quaretti P, Montagna B,
Sottotetti F, Tagliaferri B, Pozzi E, Amatu A, Pagella C and
Bernardo G: Acute thrombocytopenia: An unusual complication
occurring after drug-eluting microspheres transcatheter hepatic
chemoembolization. Cardiovasc Intervent Radiol. 34:S190–S194. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buijs M, Vossen JA, Frangakis C, Hong K,
Georgiades CS, Chen Y, Liapi E and Geschwind JF: Nonresectable
hepatocellular carcinoma: Long-term toxicity in patients treated
with transarterial chemoembolization-single-center experience.
Radiology. 249:346–354. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Michalis LK, Rees MR, Patsouras D,
Katsouras CS, Goudevenos J, Pappas S, Sourla E, Kolettis T, Sioros
L, Zotou P, et al: A prospective randomized trial comparing the
safety and efficacy of three commercially available closure devices
(Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol.
25:423–429. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brueck M, Bandorski D, Kramer W, Wieczorek
M, Höltgen R and Tillmanns H: A randomized comparison of
transradial versus transfemoral approach for coronary angiography
and angioplasty. JACC Cardiovasc Interv. 2:1047–1054. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie P and Yuan Z: Acute thrombocytopenia:
An uncommon complication occurring following transarterial
chemoembolization in a patient with neuroendocrine hepatic
metastases. Oncol Lett. 10:247–249. 2015.PubMed/NCBI
|
|
30
|
Gurakar A, Fagiuoli S, Gavaler JS,
Hassanein T, Jabbour N, Wright HI, Deal SA, Shah A, Brown M, Carr
BI, et al: The use of granulocyte-macrophage colony-stimulating
factor to enhance hematologic parameters of patients with cirrhosis
and hypersplensim. J Hepatol. 21:582–585. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Woo S, Chung JW, Hur S, Joo SM, Kim HC,
Jae HJ and Park JH: Liver abscess after transarterial
chemoembolization in patients with bilioenteric anastomosis:
Frequency and risk factors. AJR Am J Roentgenol. 200:1370–1377.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim W, Clark TW, Baum RA and Soulen MC:
Risk factors for liver abscess formation after hepatic
chemoembolization. J Vasc Interv Radiol. 12:965–968. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kirchhoff TD, Bleck JS, Dettmer A, Chavan
A, Rosenthal H, Merkesdal S, Frericks B, Zender L, Malek NP, Greten
TF, et al: Transarterial chemoembolization using degradable starch
microspheres and iodized oil in the treatment of advanced
hepatocellular carcinoma: Evaluation of tumor response, toxicity
and survival. Hepatobiliary Pancreat Dis Int. 6:259–266.
2007.PubMed/NCBI
|
